Skip to Main Content

Author Details

Feroz Khan
CSIR-Central Institute of Medicinal & Aromatic Plants
2005
146
28
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37132141Pharmacophore &amp; QSAR Guided Design, Synthesis, Pharmacokinetics and <i>In vitro</i> Evaluation of Curcumin Analogs for Anticancer Activity.Curr Med Chem2024
36089201Quebrachitol from Putranjiva roxburghii Wall. (Putranjivaceae) a potent antimalarial: Pre-clinical efficacy and its interaction with PfLDH.Parasitol Int2023
37946341Synthesis and Structural Activity Relationship Study of Ursolic Acid Derivatives as Antitubercular Agent.Med Chem2023
37149230Synthesis of 6-alkoxy and 6-hydroxy-alkyl amine derivatives of braylin as vasorelaxing agents.Bioorg Med Chem Lett2023
36838640In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of <i>M. tuberculosis</i> H37Rv: Rifampicin Derivatives Target VapC2 of <i>Mtb</i> H37Rv.Molecules2023
36731295Synthesis of amide derivatives of 3-aryl-3H-benzopyrans as osteogenic agent concomitant with anticancer activity.Bioorg Chem2023
33327922<i>In vitro</i>, <i>In vivo</i> and <i>In silico</i> Antihyperglycemic Activity of Some Semi-Synthetic Phytol Derivatives.Med Chem2022
35526254Molecular cloning and characterization of Triterpenoid Biosynthetic Pathway Gene HMGS in Centella asiatica (Linn.).Mol Biol Rep2022
36069578Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.Microbiol Spectr2022
36386946Investigation of the potential of <i>Glycyrrhiza glabra</i> as a bioavailability enhancer of Vitamin B12.Front Nutr2022
35064430In vitro and in vivo anti-inflammatory activity of Tetrastigma sulcatum leaf extract, pure compound and its derivatives.Inflammopharmacology2022
35331094Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer.Curr Top Med Chem2022
32484109Brevifoliol and its Analogs: A New Class of Anti-tubercular Agents.Curr Top Med Chem2021
33548732Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway.Bioorg Chem2021
33902420In-silico Studies and Wet-Lab Validation of Camptothecin Derivatives for Anti-Cancer Activity Against Liver (HepG2) and Lung (A549) Cancer Cell Lines.Curr Top Med Chem2021
33859561Antihypertensive Effect of a Novel Angiotensin II Receptor Blocker Fluorophenyl Benzimidazole: Contribution of cGMP, Voltage-dependent Calcium Channels, and BK<sub>Ca</sub> Channels to Vasorelaxant Mechanisms.Front Pharmacol2021
34469711Synthesis and biological evaluation of substituted amide derivatives of C4-ageratochromene dimer analog.Bioorg Med Chem Lett2021
33969634An improved synthesis of indanocine and antiproliferative activity of 2-benzylindanocine via microtubule destabilization.Chem Biol Drug Des2021
34153643Design, synthesis and broad spectrum antibreast cancer activity of diarylindoles via induction of apoptosis in aggressive breast cancer cells.Bioorg Med Chem2021
31795747Synthesis, molecular modelling studies of indolyl chalcone derivatives and their antimalarial activity evaluation.Nat Prod Res2021
33280598Detection of Natural Inhibitors against Human Liver Cancer Cell Lines through QSAR, Molecular Docking and ADMET Studies.Curr Top Med Chem2021
306861402D- and 3D-QSAR modelling, molecular docking and <i>in vitro</i> evaluation studies on 18β-glycyrrhetinic acid derivatives against triple-negative breast cancer cell line.J Biomol Struct Dyn2020
31711783Synthesis and evaluation of substituted 8,8-dimethyl-8H-pyrano[2,3-f]chromen-2-one derivatives as vasorelaxing agents.Bioorg Med Chem Lett2020
31884407Antiproliferative activity of diarylnaphthylpyrrolidine derivative via dual target inhibition.Eur J Med Chem2020
32805425Fluorinated benzylidene indanone exhibits antiproliferative activity through modulation of microtubule dynamics and antiangiogenic activity.Eur J Pharm Sci2020
32623016Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate.J Ethnopharmacol2020
32247734Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents.Bioorg Med Chem Lett2020
32361184Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents.Bioorg Chem2020
31585016Brevifoliol ester induces apoptosis in prostate cancer cells by activation of caspase pathway.Chem Biol Drug Des2020
31514715Quantitative structure-activity relationship and molecular docking studies on human proteasome inhibitors for anticancer activity targeting NF-κB signaling pathway.J Biomol Struct Dyn2020
30663356Silymarin, a polyphenolic flavonoid impede <i>Plasmodium falciparum</i> growth through interaction with heme.Nat Prod Res2020
30580626<i>In vitro</i> antiproliferative activity of glabridin derivatives and their <i>in silico</i> target identification.Nat Prod Res2020
29595093Synergy of clavine alkaloid 'chanoclavine' with tetracycline against multi-drug-resistant E. coli.J Biomol Struct Dyn2019
31654513Exploration of Medicinal Plants as Sources of Novel Anticandidal Drugs.Curr Top Med Chem2019
302618243D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.J Biomol Struct Dyn2019
31210109In Vitro and In Silico Studies of Glycyrrhetinic Acid Derivatives as Anti- Filarial Agents.Curr Top Med Chem2019
31454535Bivalent furostene carbamates as antiproliferative and antiinflammatory agents.J Steroid Biochem Mol Biol2019
30834834In Vitro, In Silico and Ex Vivo Studies of Dihydroartemisinin Derivatives as Antitubercular Agents.Curr Top Med Chem2019
311525813-Arylindanones and related compounds as antiproliferative agents against colorectal cancer.Chem Biol Drug Des2019
31093899Characterization of a class III peroxidase from Artemisia annua: relevance to artemisinin metabolism and beyond.Plant Mol Biol2019
30977451Comparative Drug Resistance Reversal Potential of Natural Glycosides: Potential of Synergy Niaziridin &amp; Niazirin.Curr Top Med Chem2019
31025863Extended Multitarget Pharmacology of Anticancer Drugs.J Chem Inf Model2019
309320783D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition.Sci Rep2019
28763373Comparison of two radiological methods in the determination of skeletal maturity in the Indian pediatric population.J Pediatr Orthop B2018
30150996AromaDb: A Database of Medicinal and Aromatic Plant's Aroma Molecules With Phytochemistry and Therapeutic Potentials.Front Plant Sci2018
30444870Genome-wide detection of terpene synthase genes in holy basil (Ocimum sanctum L.).PLoS One2018
29615704Virtual screening, Docking, ADMET and System Pharmacology studies on Garcinia caged Xanthone derivatives for Anticancer activity.Sci Rep2018
29346071Identification of potential inhibitors against nuclear Dam1 complex subunit Ask1 of Candida albicans using virtual screening and MD simulations.Comput Biol Chem2018
28705120QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity.J Biomol Struct Dyn2018
27068291Artificial neural network-based model for the prediction of optimal growth and culture conditions for maximum biomass accumulation in multiple shoot cultures of Centella asiatica.Protoplasma2017
  • 1 - 50 of 146

Recommended Authors

University of Helsinki
Career Start Year 2016
Number of shared co-authors 0
Comsat Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
Anyang Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
National University of Sciences and Technology (NUST)
Career Start Year 2012
Number of shared co-authors 0
University of North Carolina School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Mid and South Essex NHS Foundation Trust
Career Start Year 2009
Number of shared co-authors 0
CSIR-Indian Institute of Chemical Biology
Career Start Year 2008
Number of shared co-authors 0
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Career Start Year 2007
Number of shared co-authors 0
Instituto Universitario de Bio-Organica Antonio Gonzalez, Universidad de La Laguna
Career Start Year 2006
Number of shared co-authors 0
Jilin University
Career Start Year 2005
Number of shared co-authors 0
Kohat University of Science and Technology (KUST)
Career Start Year 2004
Number of shared co-authors 0
King Abdulaziz University (KAU), King Abdulaziz University
Career Start Year 2004
Number of shared co-authors 0
Post Graduate Institute of Medical Education and Research
Career Start Year 2003
Number of shared co-authors 0
Guangxi Minzu University
Career Start Year 2002
Number of shared co-authors 0
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Research Institute for Medical and Health Sciences, University of Sharjah
Career Start Year 2001
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 2001
Number of shared co-authors 0
National Institute of Chemistry
Career Start Year 2000
Number of shared co-authors 1
International Centre for Genetic Engineering and Biotechnology (ICGEB)
Career Start Year 2000
Number of shared co-authors 0
Moffitt Cancer Center and Research Institute
Career Start Year 1999
Number of shared co-authors 0
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
University of New Mexico School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Career Start Year 1994
Number of shared co-authors 1
Middle East Technical University
Career Start Year 1994
Number of shared co-authors 0
National Center for Advancing Translational Science, 9800 Medical Center Drive
Career Start Year 1993
Number of shared co-authors 0
Institute for Physiology, Charite-University Medicine Berlin
Career Start Year 1990
Number of shared co-authors 0
International University of Health and Welfare (IUHV Hospital)
Career Start Year 1989
Number of shared co-authors 1
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
Department of Pharmaceutical Sciences, University of Perugia
Career Start Year 1986
Number of shared co-authors 0

Collaborators

University of California san francisco
Co-authored papers 5
University of California san francisco
Co-authored papers 3
Yale University
Co-authored papers 2
Quantitative Bioscience Institute, University of California san francisco
Co-authored papers 2
University of California San Francisco
Co-authored papers 1
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Co-authored papers 1
Director of Clinical Innovation
Co-authored papers 1
Korea Advanced Institute of Science and Technology (KAIST)
Co-authored papers 1
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Co-authored papers 1